CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
US4943533A
(en)
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
DE69025946T2
(de)
|
1989-09-08 |
1996-10-17 |
Univ Duke |
Modifikationen der struktur des egf-rezeptor-gens in menschlichen glioma
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
ATE208633T1
(de)
|
1994-09-16 |
2001-11-15 |
Merck Patent Gmbh |
Immunokonjugate
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
SK398A3
(en)
|
1995-07-06 |
1998-07-08 |
Novartis Ag |
Pyrrolopyrimidines and processes for the preparation thereof
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
RO121900B1
(ro)
|
1996-04-12 |
2008-07-30 |
Warner-Lambert Company |
Compuşi inhibitori, ireversibili, ai tirozin kinazelor, compoziţie farmaceutică care îi conţine şi utilizarea acestora
|
AR007857A1
(es)
|
1996-07-13 |
1999-11-24 |
Glaxo Group Ltd |
Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
WO2000031048A1
(en)
|
1998-11-19 |
2000-06-02 |
Warner-Lambert Company |
N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
|
KR100823764B1
(ko)
|
2000-06-22 |
2008-04-21 |
제넨테크, 인크. |
아고니스트 안티-티알케이-씨 모노클로날 항체
|
US7514446B2
(en)
|
2003-02-20 |
2009-04-07 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
KR20080015409A
(ko)
|
2005-05-16 |
2008-02-19 |
아스트라제네카 아베 |
티로신 키나제 억제제로서 유용한 피라졸릴아미노피리미딘 유도체
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
BRPI0611863B1
(pt)
|
2005-06-22 |
2021-11-23 |
Plexxikon, Inc |
Composto, bem como composição e kit compreendendo o mesmo, composto intermediário na preparação do mesmo, método para tratamento e uso do mesmo
|
PT1919979E
(pt)
|
2005-08-25 |
2014-03-07 |
Creabilis Therapeutics Spa |
Polímeros conjugados de k-252a e seus derivados
|
PT3184526T
(pt)
|
2005-12-13 |
2018-12-19 |
Incyte Holdings Corp |
Derivados de pirrolo[2,3-d]pirimidina como inibidores da cinase janus
|
KR101412675B1
(ko)
|
2005-12-21 |
2014-07-03 |
얀센 파마슈티카 엔.브이. |
티로신 키나제 모듈레이터로서의 트리아졸로피리다진
|
ZA200808966B
(en)
|
2006-03-27 |
2010-03-31 |
Nerviano Medical Sciences Srl |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
AU2007336811A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
CN101679408B
(zh)
*
|
2006-12-22 |
2016-04-27 |
Astex治疗学有限公司 |
作为fgfr抑制剂的双环杂环化合物
|
EP2152688A1
(en)
|
2007-05-04 |
2010-02-17 |
Irm Llc |
Compounds and compositions as c-kit and pdgfr kinase inhibitors
|
US20080312259A1
(en)
|
2007-06-13 |
2008-12-18 |
Incyte Corporation |
SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
WO2008155378A1
(en)
|
2007-06-21 |
2008-12-24 |
Janssen Pharmaceutica Nv |
Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline
|
KR20100031639A
(ko)
|
2007-07-09 |
2010-03-23 |
아스트라제네카 아베 |
증식성 질환의 치료용 삼중 치환된 피리미딘 유도체
|
BRPI0814423B1
(pt)
|
2007-07-17 |
2022-04-19 |
Plexxikon, Inc |
Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
|
AU2008279776B2
(en)
|
2007-07-19 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
PL2176231T3
(pl)
|
2007-07-20 |
2017-04-28 |
Nerviano Medical Sciences S.R.L. |
Podstawione pochodne indazolu aktywne jako inhibitory kinazy
|
JP2011501760A
(ja)
|
2007-10-23 |
2011-01-13 |
ノバルティス アーゲー |
呼吸器疾患の処置のためのtrkb抗体の使用
|
US8598172B2
(en)
|
2007-12-04 |
2013-12-03 |
Nerviano Medical Sciences S.R.L. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
CN102015769B
(zh)
|
2008-01-17 |
2014-12-10 |
Irm责任有限公司 |
改进的抗-trkb抗体
|
US8207165B2
(en)
|
2008-03-28 |
2012-06-26 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
UA103478C2
(ru)
|
2008-05-23 |
2013-10-25 |
Новартіс Аг |
Производные хинолинов и хиноксалинов как ингибиторы протеинтирозинкиназы
|
JP5767965B2
(ja)
|
2008-06-10 |
2015-08-26 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼを調節する5h−ピロロ[2,3−b]ピラジン誘導体、およびその適応症
|
NZ624345A
(en)
|
2008-06-27 |
2016-07-29 |
Celgene Avilomics Res Inc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
JP5677296B2
(ja)
|
2008-07-29 |
2015-02-25 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
グリオーマの治療のためのcdk阻害剤の使用
|
JP2011530511A
(ja)
*
|
2008-08-05 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
治療用化合物
|
US8394802B2
(en)
|
2008-09-19 |
2013-03-12 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases
|
CN103965200B
(zh)
|
2008-09-22 |
2016-06-08 |
阵列生物制药公司 |
作为trk激酶抑制剂的取代的咪唑并[1,2-b]哒嗪化合物
|
LT3372605T
(lt)
|
2008-10-22 |
2022-02-10 |
Array Biopharma, Inc. |
Pakeistieji pirazolo[1,5-a]pirimidino junginiai, kaip trk kinazės inhibitoriai
|
WO2010058006A1
(en)
|
2008-11-24 |
2010-05-27 |
Nerviano Medical Sciences S.R.L. |
Cdk inhibitor for the treatment of mesothelioma
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
CN106967070A
(zh)
|
2009-05-22 |
2017-07-21 |
因塞特控股公司 |
作为jak抑制剂的化合物
|
WO2010145998A1
(en)
|
2009-06-15 |
2010-12-23 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
EA201200260A1
(ru)
|
2009-08-12 |
2012-09-28 |
Новартис Аг |
Гетероциклические гидразоны и их применение для лечения рака и воспаления
|
RU2595718C2
(ru)
|
2009-09-09 |
2016-08-27 |
Селджен Авиломикс Рисерч,Инк. |
Ингибиторы pi3-киназы и их применение
|
BR112012008267B1
(pt)
|
2009-10-09 |
2022-10-04 |
Incyte Holdings Corporation |
Derivados hidroxila, ceto e glucuronida de 3-(4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1- il)-3-ciclopentilpropanonitrila
|
WO2011092120A1
(en)
|
2010-01-29 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
|
WO2011101408A1
(en)
|
2010-02-18 |
2011-08-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for preventing cancer metastasis
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
KR102132405B1
(ko)
|
2010-05-20 |
2020-07-09 |
어레이 바이오파마 인크. |
Trk 키나제 저해제로서의 매크로시클릭 화합물
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
EP2668190B1
(en)
|
2011-01-26 |
2016-08-17 |
Nerviano Medical Sciences S.r.l. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
JP5925808B2
(ja)
|
2011-01-26 |
2016-05-25 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用
|
MA34948B1
(fr)
|
2011-02-07 |
2014-03-01 |
Plexxikon Inc |
Composes et procedes de modulation de kinase, et leurs indications
|
US9199979B2
(en)
|
2011-02-24 |
2015-12-01 |
Nerviano Medical Sciences S.R.L. |
Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
|
JP5959541B2
(ja)
|
2011-02-25 |
2016-08-02 |
ノバルティス アーゲー |
Trk阻害剤としてのピラゾロ[1,5−a]ピリジン
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
RU2621732C2
(ru)
|
2011-04-19 |
2017-06-07 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
|
HUE031166T2
(hu)
|
2011-05-12 |
2017-07-28 |
Nerviano Medical Sciences Srl |
Kináz inhibitorként aktív szubsztituált indazolok
|
BR112013029201B1
(pt)
|
2011-05-13 |
2022-08-09 |
Array Biopharma Inc |
Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas
|
EP2736514B1
(en)
|
2011-07-28 |
2017-10-18 |
Nerviano Medical Sciences S.r.l. |
Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
|
EP2788351B1
(en)
|
2011-10-07 |
2017-06-28 |
Nerviano Medical Sciences S.r.l. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASE INHIBITORS
|
EP2788350B1
(en)
|
2011-10-07 |
2017-12-06 |
Nerviano Medical Sciences S.r.l. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
EP2779833A4
(en)
|
2011-11-14 |
2015-03-18 |
Tesaro Inc |
MODULATION OF SPECIFIC TYROSINE KINASES
|
EP2791242A1
(en)
|
2011-12-12 |
2014-10-22 |
Sa Des Eaux Minerales d'Evian Saeme |
Plastic compositions and containers made thereof
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
JP6160613B2
(ja)
|
2012-04-26 |
2017-07-12 |
小野薬品工業株式会社 |
Trk阻害化合物
|
NZ703124A
(en)
|
2012-05-23 |
2016-07-29 |
Nerviano Medical Sciences Srl |
Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
PT3495367T
(pt)
|
2012-06-13 |
2020-11-12 |
Incyte Holdings Corp |
Compostos tricíclicos substituídos como inibidores de fgfr
|
KR102163776B1
(ko)
|
2012-07-11 |
2020-10-12 |
블루프린트 메디신즈 코포레이션 |
섬유아세포 성장인자 수용체의 저해제
|
BR112015001724A2
(pt)
|
2012-07-27 |
2018-04-03 |
Genentech Inc |
métodos de tratamento de condições relacionadas a fgfr3
|
EP2880025B1
(en)
|
2012-08-02 |
2018-12-05 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrroles active as kinases inhibitors
|
WO2014072220A1
(en)
|
2012-11-07 |
2014-05-15 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
UA116455C2
(uk)
|
2012-11-13 |
2018-03-26 |
Еррей Біофарма Інк. |
Сполуки n-піролідинілсечовини, n'-піразолілсечовини, тіосечовини, гуанідину та ціаногуанідину як інгібітори кінази trka
|
US9546156B2
(en)
|
2012-11-13 |
2017-01-17 |
Array Biopharma Inc. |
N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
RU2664541C2
(ru)
|
2012-11-13 |
2018-08-20 |
Эррэй Биофарма Инк. |
Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
BR112015002626A2
(pt)
|
2012-11-29 |
2017-09-26 |
Yeda Res & Dev |
métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
|
SG11201506514QA
(en)
|
2013-02-19 |
2015-09-29 |
Ono Pharmaceutical Co |
Trk-INHIBITING COMPOUND
|
CN105246511A
(zh)
|
2013-03-06 |
2016-01-13 |
豪夫迈·罗氏有限公司 |
治疗和预防癌症药物抗性的方法
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
US9850038B2
(en)
|
2013-03-15 |
2017-12-26 |
Reynolds Presto Products Inc. |
Child resistant zipper closure for recloseable pouch with double slider and methods
|
ES2646019T3
(es)
|
2013-05-14 |
2017-12-11 |
Nerviano Medical Sciences S.R.L. |
Derivados de 6-amino-7-deaza-purina, proceso para su preparación y su uso como inhibidores de cinasa
|
SG11201509338QA
(en)
|
2013-05-30 |
2015-12-30 |
Plexxikon Inc |
Compounds for kinase modulation, and indications therefor
|
US10407509B2
(en)
|
2013-07-30 |
2019-09-10 |
Blueprint Medicines Corporation |
NTRK2 fusions
|
WO2015017528A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
US9840517B2
(en)
|
2013-09-18 |
2017-12-12 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Compound inhibiting activities of BTK and/or JAK3 kinases
|
TWI664977B
(zh)
|
2013-10-08 |
2019-07-11 |
第一三共股份有限公司 |
抗fgfr2抗體及其與其他藥劑之組合
|
DK3057969T3
(en)
|
2013-10-17 |
2018-09-24 |
Blueprint Medicines Corp |
COMPOSITIONS USED FOR TREATMENT OF DISEASES RELATED TO ENZYMETE KIT
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
JP6458023B2
(ja)
|
2013-10-25 |
2019-01-23 |
ブループリント メディシンズ コーポレイション |
繊維芽細胞成長因子受容体の阻害剤
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
MY193524A
(en)
|
2014-01-24 |
2022-10-18 |
Turning Point Therapeutics Inc |
Diaryl macrocycles as modulators of protein kinases
|
DK3102577T3
(en)
|
2014-02-07 |
2018-11-12 |
Principia Biopharma Inc |
QUINOLONDERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ros1突變癌細胞之分子
|
US11037129B1
(en)
|
2014-02-24 |
2021-06-15 |
Groupon, Inc. |
Consumer device presence-based transaction session
|
EP3848034A1
(en)
|
2014-03-26 |
2021-07-14 |
Astex Therapeutics Limited |
Cmet-inhibitors for use in delaying the emergence in resistance to fgfr inhibitors
|
EP3132054B1
(en)
|
2014-04-18 |
2021-06-30 |
Blueprint Medicines Corporation |
Met fusions
|
EP3132056B1
(en)
|
2014-04-18 |
2021-11-24 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
RS59286B1
(sr)
|
2014-05-15 |
2019-10-31 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea kao inhibitor trka kinaze
|
EA028614B1
(ru)
|
2014-05-22 |
2017-12-29 |
Общество С Ограниченной Ответственностью "Русские Фармацевтические Технологии" |
Селективные ингибиторы, нарушающие взаимодействие рецептора фактора роста фибробластов и frs2, для профилактики и лечения рака
|
WO2015191667A1
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Pkn1 fusions
|
US10378063B2
(en)
|
2014-06-10 |
2019-08-13 |
Blueprint Medicines Corporation |
RAF1 fusions
|
US9949971B2
(en)
|
2014-06-17 |
2018-04-24 |
Acerta Pharma B.V. |
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
|
US10370725B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
FGR fusions
|
US10370724B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
PRKC fusions
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
CN110655502A
(zh)
|
2014-08-18 |
2020-01-07 |
小野药品工业株式会社 |
抑制Trk的化合物的酸加成盐
|
JP6421241B2
(ja)
|
2014-11-14 |
2018-11-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
タンパク質キナーゼ阻害剤としての6−アミノ−7−ビシクロ−7−デアザ−プリン誘導体
|
RS64122B1
(sr)
|
2014-11-16 |
2023-05-31 |
Array Biopharma Inc |
Kristalni oblik (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamid hidrogensulfata
|
EP3221700B1
(en)
|
2014-11-18 |
2022-06-22 |
Blueprint Medicines Corporation |
Prkacb fusions
|
US9909016B2
(en)
|
2015-02-28 |
2018-03-06 |
Matthew Fontaine |
Elastomeric coating composition
|
US20180237424A1
(en)
|
2015-03-03 |
2018-08-23 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Fgfr3 antagonists
|
WO2016191172A1
(en)
|
2015-05-22 |
2016-12-01 |
Principia Biopharma Inc. |
Quinolone derivatives as fibroblast growth factor receptor inhibitors
|
JP6887997B2
(ja)
|
2015-10-02 |
2021-06-16 |
フレックスデックス, インク.Flexdex, Inc. |
無制限ロールを付与するハンドル機構
|
US9640210B1
(en)
|
2015-11-13 |
2017-05-02 |
Kabushiki Kaisha Toshiba |
Virtual window mode for guide spiral servo demodulation
|
AU2017317864B2
(en)
*
|
2016-09-01 |
2020-01-16 |
Transthera Sciences (Nanjing), Inc. |
Inhibitors of fibroblast growth factor receptor and use thereof
|
CN108082275B
(zh)
|
2016-11-23 |
2021-08-24 |
操纵技术Ip控股公司 |
电动转向系统
|